Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

    Recruiting
    • Relapsed/Refractory B-cell Lymphomas
    • +11 more
    • CLBR001 and SWI019
    • Duarte, California
    • +7 more
    Jul 26, 2022

    DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

    Terminated
    • Diffuse Large B-Cell Lymphoma
    • +4 more
    • Ublituximab
    • +2 more
    • Birmingham, Alabama
    • +167 more
    Jul 20, 2022

    Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

    Active, not recruiting
    Has Results
    • Mantle Cell Lymphoma
    • Tampa, Florida
    • +3 more
    Mar 26, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Collecting and Storing Tissue Samples From Rare or Cutaneous

    Active, not recruiting
    • Adult Immunoblastic Lymphoma
    • +12 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +129 more
    Mar 23, 2022

    Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +9 more
    • NKX019
    • Denver, Colorado
    • +6 more
    Jan 19, 2022

    Mantle Cell Lymphoma Trial in United States (bortezomib)

    Active, not recruiting
    Has Results
    • Mantle Cell Lymphoma
    • San Francisco, California
    • +47 more
    Aug 16, 2021

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Entospletinib MM
    • Entospletinib SDD
    • Birmingham, Alabama
    • +47 more
    Nov 2, 2020

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

    Completed
    Has Results
    • B-cell Chronic Lymphocytic Leukemia
    • +9 more
    • Stanford, California
    • +15 more
    May 14, 2020

    Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

    Terminated
    Has Results
    • Mantle Cell Lymphoma
    • Non-Hodgkin's Lymphoma
    • San Diego, California
    • +91 more
    Nov 6, 2019

    Mantle Cell Lymphoma Trial in Worldwide (lenalidomide)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Little Rock, Arkansas
    • +69 more
    Dec 11, 2018

    Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Tucson, Arizona
    • +127 more
    Jan 8, 2018

    Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Completed
    • Mantle Cell Lymphoma
    • La Jolla, California
    • +56 more
    May 27, 2016

    Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

    Completed
    • Follicular Lymphoma
    • +4 more
    • Birmingham, Alabama
    • +10 more
    Jun 24, 2011

    Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

    Completed
    • Mantle Cell Lymphoma
    • VELCADE TM (bortezomib) for Injection
    • Birmingham, Alabama
    • +34 more
    Feb 7, 2008

    Mantle Cell Lymphoma Trial in Chicago, New York, Philadelphia (Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin,

    Completed
    • Mantle Cell Lymphoma
    • Iodine-131 Anti-B1 Antibody
    • Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)
    • Chicago, Illinois
    • +2 more
    Jun 23, 2005